|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.82 USD | -2.87% |
|
+2.96% | +29.22% |
| 07-08 | Prime Medicine Receives Favorable Ruling in Beam Therapeutics License Arbitration; Shares Rise | MT |
| 07-08 | Prime Medicine Receives Favorable Ruling in Beam Therapeutics License Arbitration | MT |
| Market Cap | 3.57B 3.12B 2.88B 2.66B 5.05B 340B 5.14B 34.45B 13.5B 167B 13.38B 13.1B 579B | P/E 2026 * |
-8.2x | P/E 2027 * | -7.87x |
|---|---|---|---|---|---|
| Enterprise Value | 2.71B 2.37B 2.19B 2.02B 3.84B 259B 3.9B 26.19B 10.27B 127B 10.18B 9.96B 440B | EV / Sales 2026 * |
35.8x | EV / Sales 2027 * | 26.2x |
| Free-Float |
98.6% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Beam Therapeutics Inc.
| 1 day | -2.87% | ||
| 1 week | +2.96% | ||
| Current month | +4.37% | ||
| 1 month | +17.56% | ||
| 3 months | +36.04% | ||
| 6 months | +30.02% | ||
| Current year | +29.22% |
| 1 week | 33.73 |  | 38.26 |
| 1 month | 28.67 | | 38.26 |
| Current year | 21.63 | | 38.26 |
| 1 year | 15.6 | | 38.26 |
| 3 years | 13.52 | | 49.5 |
| 5 years | 13.52 | | 116.91 |
| 10 years | 13 | | 138.52 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Evans
CEO | Chief Executive Officer | 48 | 31/12/2016 |
| President | 57 | 23/01/2020 | |
Sravan Emany
DFI | Director of Finance/CFO | 48 | 18/12/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
John Evans
BRD | Director/Board Member | 48 | 31/12/2016 |
Mark Fishman
BRD | Director/Board Member | 75 | 30/04/2018 |
Graham Cooper
BRD | Director/Board Member | 56 | 09/10/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-29 | Fiscal year | Chief Executive Officer | 75,000 | 0.0729% | ||
| 06-29 | Sell | Chief Technology Officer | -373 | 0.0004% | ||
| 06-25 | F-Prime Inc.
| Sell | Company | -251,488 | 0.2444% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.87% | +2.96% | +66.92% | +17.60% | 3.57B | |
| +1.17% | +2.68% | +3.55% | +11.54% | 50.44B | |
| +0.72% | +1.00% | +396.18% | +624.25% | 40.63B | |
| +2.54% | +0.93% | +28.98% | -3.62% | 34.88B | |
| +0.31% | +1.74% | +18.44% | +59.76% | 33.67B | |
| -2.09% | -1.98% | +3.21% | +33.56% | 26.29B | |
| -0.63% | +0.34% | - | - | 17.11B | |
| +0.66% | -3.96% | +66.85% | +127.36% | 15.29B | |
| -23.90% | -21.43% | +50.06% | +53.83% | 10.62B | |
| +1.13% | +0.35% | +14.81% | +22.23% | 13.74B | |
| Average | -2.22% | -2.14% | +72.11% | +105.17% | 24.62B | |
| Weighted average by Cap. | -0.36% | -0.55% | +87.24% | +137.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 75.74M 66.25M 61.1M 56.53M 107M 7.23B 109M 732M 287M 3.55B 284M 278M 12.3B | 91.37M 79.93M 73.71M 68.2M 129M 8.72B 132M 883M 346M 4.28B 343M 336M 14.84B |
| Net income | -463M -405M -374M -346M -656M -44.2B -667M -4.47B -1.75B -21.7B -1.74B -1.7B -75.18B | -519M -454M -419M -387M -735M -49.53B -747M -5.01B -1.97B -24.32B -1.95B -1.91B -84.26B |
| Net Debt | -855M -748M -689M -638M -1.21B -81.57B -1.23B -8.26B -3.24B -40.06B -3.21B -3.14B -139B | -1.17B -1.03B -945M -875M -1.66B -112B -1.69B -11.32B -4.44B -54.93B -4.4B -4.3B -190B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/07/26 | US$35.82 | -2.87% | 2,508,825 |
| 08/07/26 | US$36.88 | -2.74% | 3,931,070 |
| 07/07/26 | US$37.92 | +7.36% | 3,941,683 |
| 06/07/26 | US$35.32 | +1.52% | 2,404,218 |
| 02/07/26 | US$34.79 | +3.91% | 2,316,284 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BEAM Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
